APASL Oncology 2022 (APASL STC in Takamatsu).

APASL Oncology 2022 (APASL STC in Takamatsu)


The Organizing Committee recognizes the excellence of the papers in the presentation for The Asian Pacific Association for the Study of the Liver Oncology 2022 Takamatsu held on September 1-3, 2022 in Takamatsu Japan (Hybrid Meeting). Congratulations!!

Presidential Award

Investigator Award

Information of Awards

The excellent papers will be awarded (for both overseas/domestic, both online/on-site attendees)

Presidential Award:JPY 50,000
Investigator Award:JPY 10,000
  • For On-site attendees, Travel Award will be awarded to the excellent presenters.
Travel Award-Overseas (for overseas attendees who attend on-site):JPY 100,000
Trave Award-Domestic (for domestic attendees who attend on-site):JPY 50,000

(There are no Travel Award options on the form. It will be selected by the organizing committee.)

Call for Abstract

Abstract Submission

Abstract Submission has been closed. Thank you for the large number of submission!

Please go to the Online Abstract Submission Form by clicking below.

If you have already submitted your abstract, and would like to view, edit or delete the abstract, please go to the View/Edit/Delete page by clicking below.

(Submission No. and Password are required to enter the page.)

Conditions for Submission Abstract for APASL Oncology 2022 in Takamatsu

  • The Scientific Committee of APASL Oncology 2022 in Takamatsu will only accept original scientific material, which has not been published before. However, abstracts presented at local, regional or national meetings may be submitted.
  • Abstracts should be submitted in English.
  • The abstract is requested to start with the Background, continue with the Methods, Results, and finalized with the Conclusions.
  • The abstract must not exceed 250 words.
  • The category (one or two) defining the abstract must be chosen and marked on the form.
  • Preferred type of the presentation (oral, poster) must be marked on the form.
  • If there is any graphs, tables/statics or pictures, please send them to the congress secretariat info@apaslstc-takamatsu2022.org attached by jpg file, with your email subject as "figures for submission No. xxx (your submission no.)" after abstract online-submission has been completed.
  • Maximum size of any images is 1024 x 768 pixels.
  • Case report is acceptable.
  • The presenting author is required to complete conference pre-registration.


Clinical Research of Hepatocellular Carcinoma (HCC)
Epidemiology of HCC in Asia
Biomarker and Diagnosis of HCC
Imaging of HCC
Treatment for Early-Stage HCC
Treatment for Intermediate-Stage HCC
Treatment for Advanced HCC
Surgical Treatment
Liver Transplantation
Interventional Radiology (IVR)
Radiofrequency Ablation (RFA)/ Microwave Coagulo-necrotic Therapy (MCN)
Immuno-Oncotherapy/ Molecularly Targeted Drugs
Prevention of HCC Occurrence and Recurrence
HCC and Other Organs
Portal Hypertension
Cirrhosis and Complications
Nutrient Metabolism / Trace Elements
Case Report(s) and Miscellaneous
HCC and Viral Hepatitis - Clinical
HCC and Other Infection in Liver Disease- Clinical
HCC and Nonalcoholic Fatty Liver Disease - Clinical
HCC and Alcoholic Liver Disease- Clinical
HCC and Autoimmune / Cholestatic Disease- Clinical
HCC and Fibrosis / Cirrhosis - Clinical
HCC and Metabolic / Genetic Disease- Clinical
Basic Research of Hepatocellular Carcinoma (HCC)
HCC and Hepatitis B - Basic
HCC and Hepatitis C - Basic
HCC and Other Infection in Liver Disease- Basic
HCC and Nonalcoholic Fatty Liver Disease - Basic
HCC and Alcoholic Liver Disease- Basic
HCC and Autoimmune / Cholestatic Disease- Basic
HCC and Fibrosis / Cirrhosis- Basic
HCC and Metabolic / Genetic Disease- Basic
HCC and Genome Sciences- Basic
HCC and MicroRNA- Basic
Cholangiocellular Cancer (CCC)
Basic Research
Clinical Research
Metastatic Liver Cance
Basic Research
Clinical Research
Other Hepatobiliary Neoplasia
Basic Research
Clinical Research